{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:31:21Z","timestamp":1780122681113,"version":"3.54.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11030-022-10475-9","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T12:17:01Z","timestamp":1655986621000},"page":"1141-1162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Discovery of potential mTOR inhibitors from Cichorium intybus to find new candidate drugs targeting the pathological protein related to the breast cancer: an integrated computational approach"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5250-003X","authenticated-orcid":false,"given":"Hezha O.","family":"Rasul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakhtyar K.","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dlzar D.","family":"Ghafour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Kivrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"10475_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3322\/caac.21220","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, DeSantis C, Jemal A (2014) Colorectal cancer statistics, 2014. CA Cancer J Clin 64:104\u2013117. https:\/\/doi.org\/10.3322\/caac.21220","journal-title":"CA Cancer J Clin"},{"key":"10475_CR2","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1200\/JCO.2005.66.130","volume":"23","author":"S Chan","year":"2005","unstructured":"Chan S, Scheulen ME, Johnston S et al (2005) Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer. J Clin Oncol 23:5314\u20135322. https:\/\/doi.org\/10.1200\/JCO.2005.66.130","journal-title":"J Clin Oncol"},{"key":"10475_CR3","doi-asserted-by":"crossref","unstructured":"Castellanos M, Gubern C, Kadar E (2016) mTOR: exploring a new potential therapeutic target for stroke. In: Molecules to medicine with mTOR. Elsevier, pp 105\u2013122","DOI":"10.1016\/B978-0-12-802733-2.00012-8"},{"key":"10475_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274\u2013293. https:\/\/doi.org\/10.1016\/j.cell.2012.03.017","journal-title":"Cell"},{"key":"10475_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-020-00396-1","volume":"10","author":"Z Zou","year":"2020","unstructured":"Zou Z, Tao T, Li H, Zhu X (2020) mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Biosci 10:1\u201311. https:\/\/doi.org\/10.1186\/s13578-020-00396-1","journal-title":"Cell Biosci"},{"key":"10475_CR6","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1001\/jamaoncol.2019.2525","volume":"5","author":"N Unni","year":"2019","unstructured":"Unni N, Arteaga CL (2019) Is dual mTORC1 and mTORC2 therapeutic blockade clinically feasible in cancer? JAMA Oncol 5:1564\u20131565. https:\/\/doi.org\/10.1001\/jamaoncol.2019.2525","journal-title":"JAMA Oncol"},{"key":"10475_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrg1879","volume":"7","author":"JA Engelman","year":"2006","unstructured":"Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606\u2013619. https:\/\/doi.org\/10.1038\/nrg1879","journal-title":"Nat Rev Genet"},{"key":"10475_CR8","doi-asserted-by":"publisher","unstructured":"Samuels Y, Wang Z, Bardelli A, et al (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science (80-). https:\/\/doi.org\/10.1126\/science.1096502","DOI":"10.1126\/science.1096502"},{"key":"10475_CR9","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3109\/10428194.2011.580478","volume":"52","author":"J Gera","year":"2011","unstructured":"Gera J, Lichtenstein A (2011) The mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma. Leuk Lymphoma 52:1857\u20131866. https:\/\/doi.org\/10.3109\/10428194.2011.580478","journal-title":"Leuk Lymphoma"},{"key":"10475_CR10","doi-asserted-by":"publisher","unstructured":"Dowling RJO, Topisirovic I, Fonseca BD, Sonenberg N (2010) Dissecting the role of mTOR: lessons from mTOR inhibitors. Biochim Biophys Acta (BBA)-Proteins Proteom 1804:433\u2013439. https:\/\/doi.org\/10.1016\/j.bbapap.2009.12.001","DOI":"10.1016\/j.bbapap.2009.12.001"},{"key":"10475_CR11","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/molecules26041103","volume":"26","author":"S Vittorio","year":"2021","unstructured":"Vittorio S, Gitto R, Adornato I et al (2021) In silico strategy for targeting the mTOR kinase at rapamycin binding site by small molecules. Molecules 26:1103. https:\/\/doi.org\/10.3390\/molecules26041103","journal-title":"Molecules"},{"key":"10475_CR12","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.3390\/molecules25173991","volume":"25","author":"NN Zulkipli","year":"2020","unstructured":"Zulkipli NN, Zakaria R, Long I et al (2020) In silico analyses and cytotoxicity study of Asiaticoside and Asiatic acid from Malaysian plant as potential mTOR inhibitors. Molecules 25:3991. https:\/\/doi.org\/10.3390\/molecules25173991","journal-title":"Molecules"},{"key":"10475_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm3025","volume":"12","author":"R Zoncu","year":"2011","unstructured":"Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol cell Biol 12:21\u201335. https:\/\/doi.org\/10.1038\/nrm3025","journal-title":"Nat Rev Mol cell Biol"},{"key":"10475_CR14","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 168:960\u2013976. https:\/\/doi.org\/10.1016\/j.cell.2017.02.004","journal-title":"Cell"},{"key":"10475_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","volume":"18","author":"D Mossmann","year":"2018","unstructured":"Mossmann D, Park S, Hall MN (2018) mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer 18:744\u2013757. https:\/\/doi.org\/10.1038\/s41568-018-0074-8","journal-title":"Nat Rev Cancer"},{"key":"10475_CR16","first-page":"383","volume":"7","author":"SH Hare","year":"2017","unstructured":"Hare SH, Harvey AJ (2017) mTOR function and therapeutic targeting in breast cancer. Am J Cancer Res 7:383","journal-title":"Am J Cancer Res"},{"key":"10475_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-019-0754-1","volume":"12","author":"H Hua","year":"2019","unstructured":"Hua H, Kong Q, Zhang H et al (2019) Targeting mTOR for cancer therapy. J Hematol Oncol 12:1\u201319. https:\/\/doi.org\/10.1186\/s13045-019-0754-1","journal-title":"J Hematol Oncol"},{"key":"10475_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1634\/theoncologist.2011-S1-12","volume":"16","author":"J Baselga","year":"2011","unstructured":"Baselga J (2011) Targeting the phosphoinositide-3 (PI3) kinase pathway in breast cancer. Oncologist 16:12\u201319. https:\/\/doi.org\/10.1634\/theoncologist.2011-S1-12","journal-title":"Oncologist"},{"key":"10475_CR19","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1158\/1078-0432.CCR-09-1173","volume":"15","author":"S Di Cosimo","year":"2009","unstructured":"Di Cosimo S, Baselga J (2009) Phosphoinositide 3-kinase mutations in breast cancer: a \u201cgood\u201d activating mutation? Clin Cancer Res 15:5017\u20135019. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-1173","journal-title":"Clin Cancer Res"},{"key":"10475_CR20","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1158\/0008-5472.CAN-07-6854","volume":"68","author":"K Stemke-Hale","year":"2008","unstructured":"Stemke-Hale K, Gonzalez-Angulo AM, Lluch A et al (2008) An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res 68:6084\u20136091. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-6854","journal-title":"Cancer Res"},{"key":"10475_CR21","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1042\/CS20150149","volume":"129","author":"U Saran","year":"2015","unstructured":"Saran U, Foti M, Dufour J-F (2015) Cellular and molecular effects of the mTOR inhibitor everolimus. Clin Sci 129:895\u2013914. https:\/\/doi.org\/10.1042\/CS20150149","journal-title":"Clin Sci"},{"key":"10475_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-45319-4","volume":"9","author":"C-T Kuo","year":"2019","unstructured":"Kuo C-T, Chen C-L, Li C-C et al (2019) Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models. Sci Rep 9:1\u201311. https:\/\/doi.org\/10.1038\/s41598-019-45319-4","journal-title":"Sci Rep"},{"key":"10475_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s13577-019-00270-4","volume":"33","author":"D Cio\u0142czyk-Wierzbicka","year":"2020","unstructured":"Cio\u0142czyk-Wierzbicka D, Gil D, Zarzycka M, Laidler P (2020) mTOR inhibitor everolimus reduces invasiveness of melanoma cells. Hum Cell 33:88\u201397. https:\/\/doi.org\/10.1007\/s13577-019-00270-4","journal-title":"Hum Cell"},{"key":"10475_CR24","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/neuonc\/nov152","volume":"17","author":"JP MacKeigan","year":"2015","unstructured":"MacKeigan JP, Krueger DA (2015) Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex. Neuro Oncol 17:1550\u20131559. https:\/\/doi.org\/10.1093\/neuonc\/nov152","journal-title":"Neuro Oncol"},{"key":"10475_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3390\/ijms20030755","volume":"20","author":"T Tian","year":"2019","unstructured":"Tian T, Li X, Zhang J (2019) mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy. Int J Mol Sci 20:755. https:\/\/doi.org\/10.3390\/ijms20030755","journal-title":"Int J Mol Sci"},{"key":"10475_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/579319","author":"RA Street","year":"2013","unstructured":"Street RA, Sidana J, Prinsloo G (2013) Cichorium intybus: Traditional uses, phytochemistry, pharmacology, and toxicology. Evid-Based Complement Altern Med. https:\/\/doi.org\/10.1155\/2013\/579319","journal-title":"Evid-Based Complement Altern Med"},{"key":"10475_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/jsfa.817","volume":"81","author":"HP Bais","year":"2001","unstructured":"Bais HP, Ravishankar GA (2001) Cichorium intybus L\u2013cultivation, processing, utility, value addition and biotechnology, with an emphasis on current status and future prospects. J Sci Food Agric 81:467\u2013484. https:\/\/doi.org\/10.1002\/jsfa.817","journal-title":"J Sci Food Agric"},{"key":"10475_CR28","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1002\/jsfa.817","volume":"20","author":"Y Wang","year":"2019","unstructured":"Wang Y, Lin Z, Zhang B et al (2019) Cichorium intybus L. extract suppresses experimental gout by inhibiting the NF-\u03baB and NLRP3 signaling pathways. Int J Mol Sci 20:4921. https:\/\/doi.org\/10.1002\/jsfa.817","journal-title":"Int J Mol Sci"},{"key":"10475_CR29","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.21474\/IJAR01\/1990","volume":"4","author":"S Chandra","year":"2016","unstructured":"Chandra S, Kumar M, Dwivedi P, Arti K (2016) Studies on industrial importance and medicinal value of chicory plant (Cichorium intybus L.). Int J Adv Res 4:1060\u20131071","journal-title":"Int J Adv Res"},{"key":"10475_CR30","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1096\/fj.201601071R","volume":"31","author":"Q Liu","year":"2017","unstructured":"Liu Q, Chen Y, Shen C et al (2017) Chicoric acid supplementation prevents systemic inflammation-induced memory impairment and amyloidogenesis via inhibition of NF-\u03baB. FASEB J 31:1494\u20131507. https:\/\/doi.org\/10.1096\/fj.201601071R","journal-title":"FASEB J"},{"key":"10475_CR31","doi-asserted-by":"publisher","first-page":"e0121549","DOI":"10.1371\/journal.pone.0121549","volume":"10","author":"YS El-Sayed","year":"2015","unstructured":"El-Sayed YS, Lebda MA, Hassinin M, Neoman SA (2015) Chicory (Cichorium intybus L.) root extract regulates the oxidative status and antioxidant gene transcripts in CCl4-induced hepatotoxicity. PLoS ONE 10:e0121549. https:\/\/doi.org\/10.1371\/journal.pone.0121549","journal-title":"PLoS ONE"},{"key":"10475_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jep.2012.06.036","volume":"143","author":"I S\u00fcntar","year":"2012","unstructured":"S\u00fcntar I, Akkol EK, Keles H et al (2012) Comparative evaluation of traditional prescriptions from Cichorium intybus L. for wound healing: stepwise isolation of an active component by in vivo bioassay and its mode of activity. J Ethnopharmacol 143:299\u2013309. https:\/\/doi.org\/10.1016\/j.jep.2012.06.036","journal-title":"J Ethnopharmacol"},{"key":"10475_CR33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12011-018-1392-0","volume":"187","author":"S Behboodi","year":"2019","unstructured":"Behboodi S, Baghbani-Arani F, Abdalan S, Shandiz SAS (2019) Green engineered biomolecule-capped silver nanoparticles fabricated from Cichorium intybus extract: in vitro assessment on apoptosis properties toward human breast cancer (MCF-7) cells. Biol Trace Elem Res 187:392\u2013402. https:\/\/doi.org\/10.1007\/s12011-018-1392-0","journal-title":"Biol Trace Elem Res"},{"key":"10475_CR34","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0367-326X(02)00232-0","volume":"73","author":"B Hazra","year":"2002","unstructured":"Hazra B, Sarkar R, Bhattacharyya S, Roy P (2002) Tumour inhibitory activity of chicory root extract against Ehrlich ascites carcinoma in mice. Fitoterapia 73:730\u2013733. https:\/\/doi.org\/10.1016\/S0367-326X(02)00232-0","journal-title":"Fitoterapia"},{"key":"10475_CR35","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.3390\/molecules25184160","volume":"25","author":"MF Khan","year":"2020","unstructured":"Khan MF, Nasr FA, Noman OM et al (2020) Cichorins D-F: three new compounds from Cichorium intybus and their biological effects. Molecules 25:4160. https:\/\/doi.org\/10.3390\/molecules25184160","journal-title":"Molecules"},{"key":"10475_CR36","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.3892\/or.2019.7336","volume":"42","author":"KMSU Imam","year":"2019","unstructured":"Imam KMSU, Xie Y, Liu Y et al (2019) Cytotoxicity of Cichorium intybus L. metabolites. Oncol Rep 42:2196\u20132212. https:\/\/doi.org\/10.3892\/or.2019.7336","journal-title":"Oncol Rep"},{"key":"10475_CR37","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1016\/j.fct.2008.08.004","volume":"46","author":"F Conforti","year":"2008","unstructured":"Conforti F, Ioele G, Statti GA et al (2008) Anti-proliferative activity against human tumor cell lines and toxicity test on Mediterranean dietary plants. Food Chem Toxicol 46:3325\u20133332. https:\/\/doi.org\/10.1016\/j.fct.2008.08.004","journal-title":"Food Chem Toxicol"},{"key":"10475_CR38","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1248\/bpb.23.1005","volume":"23","author":"K-T Lee","year":"2000","unstructured":"Lee K-T, Kim J-I, Park H-J et al (2000) Differentiation-inducing effect of magnolialide, a 1\u03b2-hydroxyeudesmanolide isolated from Cichorium intybus, on human leukemia cells. Biol Pharm Bull 23:1005\u20131007. https:\/\/doi.org\/10.1248\/bpb.23.1005","journal-title":"Biol Pharm Bull"},{"key":"10475_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3797\/scipharm.2007.75.121","volume":"75","author":"R Abu-Dahab","year":"2007","unstructured":"Abu-Dahab R, Afifi F (2007) Anti-proliferative activity of selected medicinal plants of Jordan against a breast adenocarcinoma cell line (MCF7). Sci Pharm 75:121\u2013146. https:\/\/doi.org\/10.3797\/scipharm.2007.75.121","journal-title":"Sci Pharm"},{"key":"10475_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.5897\/AJPS2013.1021","volume":"8","author":"M Saleem","year":"2014","unstructured":"Saleem M, Abbas K, Naseer F et al (2014) Anticancer activity of n-hexane extract of Cichorium intybus on lymphoblastic leukemia cells (Jurkat cells). African J plant Sci 8:315\u2013319. https:\/\/doi.org\/10.5897\/AJPS2013.1021","journal-title":"African J plant Sci"},{"key":"10475_CR41","first-page":"21","volume":"3","author":"A Nawab","year":"2011","unstructured":"Nawab A, Yunus M, Mahdi AA, Gupta S (2011) Evaluation of anticancer properties of medicinal plants from the Indian sub-continent. Mol Cell Pharmacol 3:21\u201329","journal-title":"Mol Cell Pharmacol"},{"key":"10475_CR42","doi-asserted-by":"publisher","DOI":"10.5812\/RIJM.38369","author":"A Rahimipour","year":"2017","unstructured":"Rahimipour A, Dehghan Nayeri N, Mehrandish R, AwsatMellati A (2017) Anti-cancer activity of methanol extracts of cichoriumintybus on human breast cancer SKBR3 Cell Line. Razavi Int J Med. https:\/\/doi.org\/10.5812\/RIJM.38369","journal-title":"Razavi Int J Med"},{"key":"10475_CR43","doi-asserted-by":"publisher","unstructured":"Esmaeilbeig M, Kouhpayeh SA, Amirghofran Z (2015) An investigation of the growth inhibitory capacity of several medicinal plants from Iran on tumor cell lines. Iran J cancer Prev. https:\/\/doi.org\/10.17795\/ijcp-4032","DOI":"10.17795\/ijcp-4032"},{"key":"10475_CR44","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1248\/cpb.36.2423","volume":"36","author":"M Seto","year":"1988","unstructured":"Seto M, Miyase T, Umehara K et al (1988) Sesquiterpene lactones from Cichorium endivia L. and C. intybus L. and cytotoxic activity. Chem Pharm Bull 36:2423\u20132429. https:\/\/doi.org\/10.1248\/cpb.36.2423","journal-title":"Chem Pharm Bull"},{"key":"10475_CR45","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.foodchem.2012.11.060","volume":"138","author":"C Carazzone","year":"2013","unstructured":"Carazzone C, Mascherpa D, Gazzani G, Papetti A (2013) Identification of phenolic constituents in red chicory salads (Cichorium intybus) by high-performance liquid chromatography with diode array detection and electrospray ionisation tandem mass spectrometry. Food Chem 138:1062\u20131071. https:\/\/doi.org\/10.1016\/j.foodchem.2012.11.060","journal-title":"Food Chem"},{"key":"10475_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.phytol.2012.10.011","volume":"6","author":"J Malarz","year":"2013","unstructured":"Malarz J, Stojakowska A, Szneler E, Kisiel W (2013) A new neolignan glucoside from hairy roots of Cichorium intybus. Phytochem Lett 6:59\u201361. https:\/\/doi.org\/10.1016\/j.phytol.2012.10.011","journal-title":"Phytochem Lett"},{"key":"10475_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.foodchem.2018.05.085","volume":"266","author":"R Tardugno","year":"2018","unstructured":"Tardugno R, Pozzebon M, Beggio M et al (2018) Polyphenolic profile of Cichorium intybus L. endemic varieties from the Veneto region of Italy. Food Chem 266:175\u2013182. https:\/\/doi.org\/10.1016\/j.foodchem.2018.05.085","journal-title":"Food Chem"},{"key":"10475_CR48","doi-asserted-by":"publisher","first-page":"M258","DOI":"10.1111\/1750-3841.12040","volume":"78","author":"H Liu","year":"2013","unstructured":"Liu H, Wang Q, Liu Y et al (2013) Antimicrobial and antioxidant activities of Cichorium intybus root extract using orthogonal matrix design. J Food Sci 78:M258\u2013M263. https:\/\/doi.org\/10.1111\/1750-3841.12040","journal-title":"J Food Sci"},{"key":"10475_CR49","doi-asserted-by":"publisher","first-page":"M398","DOI":"10.1111\/j.1750-3841.2011.02213.x","volume":"76","author":"Z Lou","year":"2011","unstructured":"Lou Z, Wang H, Zhu S et al (2011) Antibacterial activity and mechanism of action of chlorogenic acid. J Food Sci 76:M398\u2013M403. https:\/\/doi.org\/10.1111\/j.1750-3841.2011.02213.x","journal-title":"J Food Sci"},{"key":"10475_CR50","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00217-016-2810-1","volume":"243","author":"H Fan","year":"2017","unstructured":"Fan H, Chen J, Lv H et al (2017) Isolation and identification of terpenoids from chicory roots and their inhibitory activities against yeast \u03b1-glucosidase. Eur Food Res Technol 243:1009\u20131017. https:\/\/doi.org\/10.1007\/s00217-016-2810-1","journal-title":"Eur Food Res Technol"},{"key":"10475_CR51","first-page":"627","volume":"29","author":"D Jancic","year":"2017","unstructured":"Jancic D, Todorovic V, Sircelj H, et al (2017) Biologically active compounds and antioxidant capacity of Cichorium intybus L. leaves from Montenegro. Ital J Food Sci 29:627\u2013643","journal-title":"Ital J Food Sci"},{"key":"10475_CR52","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/plants10010064","volume":"10","author":"A Epure","year":"2021","unstructured":"Epure A, P\u00e2rvu AE, Vlase L et al (2021) phytochemical profile, antioxidant, cardioprotective and nephroprotective activity of Romanian chicory extract. Plants 10:64. https:\/\/doi.org\/10.3390\/plants10010064","journal-title":"Plants"},{"key":"10475_CR53","doi-asserted-by":"publisher","DOI":"10.4103\/2394-6555.180157","author":"S Das","year":"2016","unstructured":"Das S, Vasudeva N, Sharma S (2016) Cichorium intybus: a concise report on its ethnomedicinal, botanical, and phytopharmacological aspects. Drug Dev Ther. https:\/\/doi.org\/10.4103\/2394-6555.180157","journal-title":"Drug Dev Ther"},{"key":"10475_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7343928","author":"IC Nwafor","year":"2017","unstructured":"Nwafor IC, Shale K, Achilonu MC (2017) Chemical composition and nutritive benefits of chicory (Cichorium intybus) as an ideal complementary and\/or alternative livestock feed supplement. Sci World J. https:\/\/doi.org\/10.1155\/2017\/7343928","journal-title":"Sci World J"},{"key":"10475_CR55","first-page":"1736","volume":"13","author":"G WenYing","year":"2012","unstructured":"WenYing G, Li J (2012) Chicory seeds: a potential source of nutrition for food and feed. J Anim Plant Sci 13:1736\u20131746","journal-title":"J Anim Plant Sci"},{"key":"10475_CR56","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0031-9422(02)00055-9","volume":"60","author":"R N\u00f8rb\u00e6k","year":"2002","unstructured":"N\u00f8rb\u00e6k R, Nielsen K, Kondo T (2002) Anthocyanins from flowers of Cichorium intybus. Phytochemistry 60:357\u2013359. https:\/\/doi.org\/10.1016\/S0031-9422(02)00055-9","journal-title":"Phytochemistry"},{"key":"10475_CR57","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbrc.2008.09.088","volume":"377","author":"D Tousch","year":"2008","unstructured":"Tousch D, Lajoix A-D, Hosy E et al (2008) Chicoric acid, a new compound able to enhance insulin release and glucose uptake. Biochem Biophys Res Commun 377:131\u2013135. https:\/\/doi.org\/10.1016\/j.bbrc.2008.09.088","journal-title":"Biochem Biophys Res Commun"},{"key":"10475_CR58","first-page":"3311","volume":"7","author":"SS Jangra","year":"2018","unstructured":"Jangra SS, Madan VK (2018) Proximate, mineral and chemical composition of different parts of chicory (Cichorium intybus L.). J Pharmacogn Phytochem 7:3311\u20133315","journal-title":"J Pharmacogn Phytochem"},{"key":"10475_CR59","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0021-9673(00)96288-5","volume":"283","author":"E Leclercq","year":"1984","unstructured":"Leclercq E (1984) Determination of lactucin in roots of chicory (Cichorium intybus L.) by high-performance liquid chromatography. J Chromatogr A 283:441\u2013444. https:\/\/doi.org\/10.1016\/S0021-9673(00)96288-5","journal-title":"J Chromatogr A"},{"key":"10475_CR60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0031-9422(00)80838-9","volume":"24","author":"JS Pyrek","year":"1985","unstructured":"Pyrek JS (1985) Sesquiterpene lactones of Cichorium intybus and Leontodon autumnalis. Phytochemistry 24:186\u2013188. https:\/\/doi.org\/10.1016\/S0031-9422(00)80838-9","journal-title":"Phytochemistry"},{"key":"10475_CR61","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.bbrc.2004.12.061","volume":"327","author":"C Cavin","year":"2005","unstructured":"Cavin C, Delannoy M, Malnoe A et al (2005) Inhibition of the expression and activity of cyclooxygenase-2 by chicory extract. Biochem Biophys Res Commun 327:742\u2013749. https:\/\/doi.org\/10.1016\/j.bbrc.2004.12.061","journal-title":"Biochem Biophys Res Commun"},{"key":"10475_CR62","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.3390\/nu12113547","volume":"12","author":"MS Matos","year":"2020","unstructured":"Matos MS, Anast\u00e1cio JD, Allwood JW et al (2020) Assessing the intestinal permeability and anti-inflammatory potential of sesquiterpene lactones from chicory. Nutrients 12:3547. https:\/\/doi.org\/10.3390\/nu12113547","journal-title":"Nutrients"},{"key":"10475_CR63","doi-asserted-by":"publisher","unstructured":"Kisiel W, Zieli\u0144ska K (2001) Guaianolides from Cichorium intybus and structure revision of Cichorium sesquiterpene lactones. Phytochemistry 57:523\u2013527. https:\/\/doi.org\/10.1016\/S0031-9422(01)00072-3","DOI":"10.1016\/S0031-9422(01)00072-3"},{"key":"10475_CR64","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2174\/1570180054771581","volume":"2","author":"Y Ren","year":"2005","unstructured":"Ren Y, Zhou Y, Chen X, Ye Y (2005) Discovery, structural determination and anticancer activities of lactucinlike guaianolides. Lett Drug Des Discov 2:444\u2013450. https:\/\/doi.org\/10.2174\/1570180054771581","journal-title":"Lett Drug Des Discov"},{"key":"10475_CR65","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/S0031-9422(00)83015-0","volume":"24","author":"SB Rees","year":"1985","unstructured":"Rees SB, Harborne JB (1985) The role of sesquiterpene lactones and phenolics in the chemical defence of the chicory plant. Phytochemistry 24:2225\u20132231. https:\/\/doi.org\/10.1016\/S0031-9422(00)83015-0","journal-title":"Phytochemistry"},{"key":"10475_CR66","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jep.2004.06.031Get","volume":"95","author":"TA Bischoff","year":"2004","unstructured":"Bischoff TA, Kelley CJ, Karchesy Y et al (2004) Antimalarial activity of lactucin and lactucopicrin: sesquiterpene lactones isolated from Cichorium intybus L. J Ethnopharmacol 95:455\u2013457. https:\/\/doi.org\/10.1016\/j.jep.2004.06.031Get","journal-title":"J Ethnopharmacol"},{"key":"10475_CR67","first-page":"715","volume":"10","author":"B Malik","year":"2016","unstructured":"Malik B, Pirzadah TB, Tahir I et al (2016) Phytochemical studies on Cichorium intybus L. (CHICORY) from Kashmir Himalaya using GC-MS. J Pharm Res 10:715\u2013726","journal-title":"J Pharm Res"},{"key":"10475_CR68","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10493-017-0105-2","volume":"71","author":"R Ravindran","year":"2017","unstructured":"Ravindran R, Chithra ND, Deepa PE et al (2017) In vitro effects of caffeic acid, nortriptyline, precocene I and quercetin against Rhipicephalus annulatus (Acari: Ixodidae). Exp Appl Acarol 71:183\u2013193. https:\/\/doi.org\/10.1007\/s10493-017-0105-2","journal-title":"Exp Appl Acarol"},{"key":"10475_CR69","doi-asserted-by":"publisher","first-page":"22190","DOI":"10.3390\/ijms160922190","volume":"16","author":"G-Y Li","year":"2015","unstructured":"Li G-Y, Zheng Y-X, Sun F-Z et al (2015) In silico analysis and experimental validation of active compounds from Cichorium intybus L. ameliorating liver injury. Int J Mol Sci 16:22190\u201322204. https:\/\/doi.org\/10.3390\/ijms160922190","journal-title":"Int J Mol Sci"},{"key":"10475_CR70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11010-010-0655-7","volume":"349","author":"NR Prasad","year":"2011","unstructured":"Prasad NR, Karthikeyan A, Karthikeyan S, Reddy BV (2011) Inhibitory effect of caffeic acid on cancer cell proliferation by oxidative mechanism in human HT-1080 fibrosarcoma cell line. Mol Cell Biochem 349:11\u201319. https:\/\/doi.org\/10.1007\/s11010-010-0655-7","journal-title":"Mol Cell Biochem"},{"key":"10475_CR71","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10753-012-9532-8","volume":"36","author":"SJ Pragasam","year":"2013","unstructured":"Pragasam SJ, Venkatesan V, Rasool M (2013) Immunomodulatory and anti-inflammatory effect of p-coumaric acid, a common dietary polyphenol on experimental inflammation in rats. Inflammation 36:169\u2013176. https:\/\/doi.org\/10.1007\/s10753-012-9532-8","journal-title":"Inflammation"},{"key":"10475_CR72","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0031-9422(98)00555-X","volume":"50","author":"EO Krebsky","year":"1999","unstructured":"Krebsky EO, Geuns JMC, De Proft M (1999) Polyamines and sterols in Cichorium heads. Phytochemistry 50:549\u2013553. https:\/\/doi.org\/10.1016\/S0031-9422(98)00555-X","journal-title":"Phytochemistry"},{"key":"10475_CR73","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1016\/0031-9422(84)83058-7","volume":"23","author":"P Bridle","year":"1984","unstructured":"Bridle P, Loeffler RST, Timberlake CF, Self R (1984) Cyanidin 3-malonylglucoside in Cichorium intybus. Phytochemistry 23:2968\u20132969. https:\/\/doi.org\/10.1016\/0031-9422(84)83058-7","journal-title":"Phytochemistry"},{"key":"10475_CR74","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00217-009-1144-7","volume":"230","author":"V Mulabagal","year":"2009","unstructured":"Mulabagal V, Wang H, Ngouajio M, Nair MG (2009) Characterization and quantification of health beneficial anthocyanins in leaf chicory (Cichorium intybus) varieties. Eur Food Res Technol 230:47\u201353. https:\/\/doi.org\/10.1007\/s00217-009-1144-7","journal-title":"Eur Food Res Technol"},{"key":"10475_CR75","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.foodchem.2012.11.139","volume":"138","author":"AY Chen","year":"2013","unstructured":"Chen AY, Chen YC (2013) A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem 138:2099\u20132107. https:\/\/doi.org\/10.1016\/j.foodchem.2012.11.139","journal-title":"Food Chem"},{"key":"10475_CR76","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1021\/np068015j","volume":"69","author":"S Zhang","year":"2006","unstructured":"Zhang S, Zhao M, Bai L et al (2006) Bioactive guaianolides from siyekucai (Ixeris chinensis). J Nat Prod 69:1425\u20131428. https:\/\/doi.org\/10.1021\/np068015j","journal-title":"J Nat Prod"},{"key":"10475_CR77","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.foodchem.2012.10.148","volume":"138","author":"A Papetti","year":"2013","unstructured":"Papetti A, Mascherpa D, Carazzone C et al (2013) Identification of organic acids in Cichorium intybus inhibiting virulence-related properties of oral pathogenic bacteria. Food Chem 138:1706\u20131712. https:\/\/doi.org\/10.1016\/j.foodchem.2012.10.148","journal-title":"Food Chem"},{"key":"10475_CR78","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1080\/14786419.2017.1343319","volume":"32","author":"D Satmbekova","year":"2018","unstructured":"Satmbekova D, Srivedavyasasri R, Orazbekov Y et al (2018) Chemical and biological studies on Cichorium intybus L. Nat Prod Res 32:1343\u20131347. https:\/\/doi.org\/10.1080\/14786419.2017.1343319","journal-title":"Nat Prod Res"},{"key":"10475_CR79","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z et al (2000) The protein data bank. Nucl Acids Res 28:235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucl Acids Res"},{"key":"10475_CR80","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1128\/MCB.00678-12","volume":"33","author":"AM M\u00e4rz","year":"2013","unstructured":"M\u00e4rz AM, Fabian A-K, Kozany C et al (2013) Large FK506-binding proteins shape the pharmacology of rapamycin. Mol Cell Biol 33:1357\u20131367. https:\/\/doi.org\/10.1128\/MCB.00678-12","journal-title":"Mol Cell Biol"},{"key":"10475_CR81","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"10475_CR82","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2021","unstructured":"Kim S, Chen J, Cheng T et al (2021) PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res 49:D1388\u2013D1395. https:\/\/doi.org\/10.1093\/nar\/gkaa971","journal-title":"Nucleic Acids Res"},{"key":"10475_CR83","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC et al (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46:D1074\u2013D1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037","journal-title":"Nucleic Acids Res"},{"key":"10475_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA et al (2011) Open Babel: an open chemical toolbox. J Cheminform 3:1\u201314. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J Cheminform"},{"key":"10475_CR85","unstructured":"Chemaxon (2022) Chemicalize was used for [prediction of microspecies distribution]. https:\/\/chemicalize.com\/app\/calculation"},{"key":"10475_CR86","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1021\/ci900172h","volume":"49","author":"AP Harding","year":"2009","unstructured":"Harding AP, Wedge DC, Popelier PLA (2009) p K a prediction from \u201cquantum chemical topology\u201d descriptors. J Chem Inf Model 49:1914\u20131924. https:\/\/doi.org\/10.1021\/ci900172h","journal-title":"J Chem Inf Model"},{"key":"10475_CR87","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s11095-013-1232-z","volume":"31","author":"L Settimo","year":"2014","unstructured":"Settimo L, Bellman K, Knegtel R (2014) Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharm Res 31:1082\u20131095. https:\/\/doi.org\/10.1007\/s11095-013-1232-z","journal-title":"Pharm Res"},{"key":"10475_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-021-05010-w","volume":"28","author":"HO Rasul","year":"2022","unstructured":"Rasul HO, Aziz BK, Ghafour DD, Kivrak A (2022) In silico molecular docking and dynamic simulation of eugenol compounds against breast cancer. J Mol Model 28:1\u201318. https:\/\/doi.org\/10.1007\/s00894-021-05010-w","journal-title":"J Mol Model"},{"key":"10475_CR89","unstructured":"DeLano WL (2002) Pymol: an open-source molecular graphics tool. CCP4 Newsl Protein Crystallogr 40:82\u201392"},{"key":"10475_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-018-0283-x","volume":"10","author":"J Dong","year":"2018","unstructured":"Dong J, Wang N-N, Yao Z-J et al (2018) ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J Cheminform 10:1\u201311. https:\/\/doi.org\/10.1186\/s13321-018-0283-x","journal-title":"J Cheminform"},{"key":"10475_CR91","doi-asserted-by":"publisher","unstructured":"Xiong G, Wu Z, Yi J, et al (2021) ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucl Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkab255","DOI":"10.1093\/nar\/gkab255"},{"key":"10475_CR92","unstructured":"Molinspiration Cheminformatics. In: Nov. ulica. https:\/\/www.molinspiration.com\/"},{"key":"10475_CR93","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1","journal-title":"Adv Drug Deliv Rev"},{"key":"10475_CR94","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","volume":"44","author":"CA Lipinski","year":"2000","unstructured":"Lipinski CA (2000) Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44:235\u2013249. https:\/\/doi.org\/10.1016\/S1056-8719(00)00107-6","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10475_CR95","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1021\/tx900189p","volume":"22","author":"H Zhu","year":"2009","unstructured":"Zhu H, Martin TM, Ye L et al (2009) Quantitative structure\u2014activity relationship modeling of rat acute toxicity by oral exposure. Chem Res Toxicol 22:1913\u20131921. https:\/\/doi.org\/10.1021\/tx900189p","journal-title":"Chem Res Toxicol"},{"key":"10475_CR96","unstructured":"Release S (2017) 3: Desmond molecular dynamics system, DE Shaw research, New York, NY, 2017. Maest Interoperability Tools, Schr\u00f6dinger, New York"},{"key":"10475_CR97","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/90761","volume":"19","author":"J Hodgson","year":"2001","unstructured":"Hodgson J (2001) ADMET\u2014turning chemicals into drugs. Nat Biotechnol 19:722\u2013726. https:\/\/doi.org\/10.1038\/90761","journal-title":"Nat Biotechnol"},{"key":"10475_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068237","volume":"8","author":"A Beig","year":"2013","unstructured":"Beig A, Agbaria R, Dahan A (2013) Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations. PLoS ONE 8:e68237. https:\/\/doi.org\/10.1371\/journal.pone.0068237","journal-title":"PLoS ONE"},{"key":"10475_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/9780470915110","volume-title":"ADMET for medicinal chemists: a practical guide","author":"K Tsaioun","year":"2011","unstructured":"Tsaioun K, Kates SA (2011) ADMET for medicinal chemists: a practical guide. Wiley"},{"key":"10475_CR100","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1021\/acs.jcim.9b00801","volume":"59","author":"Z Wu","year":"2019","unstructured":"Wu Z, Lei T, Shen C et al (2019) ADMET evaluation in drug discovery. 19. Reliable prediction of human cytochrome P450 inhibition using artificial intelligence approaches. J Chem Inf Model 59:4587\u20134601. https:\/\/doi.org\/10.1021\/acs.jcim.9b00801","journal-title":"J Chem Inf Model"},{"key":"10475_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119264","volume":"10","author":"L Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez L (2015) Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis. PLoS ONE 10:e0119264. https:\/\/doi.org\/10.1371\/journal.pone.0119264","journal-title":"PLoS ONE"},{"key":"10475_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05641","volume":"6","author":"R Alnajjar","year":"2020","unstructured":"Alnajjar R, Mostafa A, Kandeil A, Al-Karmalawy AA (2020) Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease. Heliyon 6:e05641. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e05641","journal-title":"Heliyon"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10475-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-022-10475-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10475-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T03:37:56Z","timestamp":1686973076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-022-10475-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10475"],"URL":"https:\/\/doi.org\/10.1007\/s11030-022-10475-9","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"assertion":[{"value":"2 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest declared by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}